InsidersTradesSigma
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Discover the complete record of transactions filed by Schaffer Paul W., Director. Director active across 1 company, notably Panbela Therapeutics, Inc.. Cumulatively, 2 disclosures have been logged. Activity tracked since 25 May 2021. The latest transaction was filed on 25 May 2021 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
2 of 2 declarations
Schaffer Paul W. is a Board Member at Panbela Therapeutics, Inc. As a board member, he participates in the governance of the company and the formulation of strategies for its development in the field of medical therapies.